BOBULSKY SUSAN — SEC Form 4 filings
SEC reporting owner CIK 1820885. 13 Form 4 filings on record with FilingPulse; latest filed 2026-09-17.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-03-06 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 12 legs across 11 filings — 112,333 shares, $1,430,346 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: sale of 41,338 shares @ $13.17 ($544,421) in Adaptive Biotechnologies Corp, filed 2026-03-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Officer, MRD | 13 | — | 12 legs · 112,333 sh · $1,430,346 | 8 |
Form 4 filings — BOBULSKY SUSAN
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-17 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 1,195 @ $27 | EDGAR |
| 2026-08-12 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 3,000 @ $25 | EDGAR |
| 2026-08-03 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 1,299 @ $24 | EDGAR |
| 2026-07-20 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 5,000 @ $23 | EDGAR |
| 2026-07-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 487 @ $22 | EDGAR |
| 2026-06-29 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 5,000 @ $20.50 | EDGAR |
| 2026-06-15 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 5,000 @ $19 | EDGAR |
| 2026-06-08 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 11,000 @ $18 | EDGAR |
| 2026-03-13 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 41,338 @ $13.17 | EDGAR |
| 2026-03-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 59,375 @ $0 · Grant/award (A): 62,500 @ $0 | EDGAR |
| 2025-03-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 119,971 @ $0 · Sale (S): 26,023 @ $6.98 · Grant/award (A): 180,029 (derivative) @ $0 | EDGAR |
| 2024-10-10 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 5,000 @ $1.98 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-03-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 132,979 @ $0 · Sale (S): 6,016 @ $3.43 · Sale (S): 6,975 @ $3.44 · Grant/award (A): 199,549 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1820885 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →